VADUZ, Liechtenstein, June 24, 2025 /PRNewswire/ -- Implantica AG (publ.), a MedTech company at the forefront of introducing advanced technology into the body, including the unique device RefluxStop® for the treatment of acid reflux, a treatment field with 1 billion sufferers, announces...
Read More Details
Finally We wish PressBee provided you with enough information of ( Implantica submits the last and final module 3 of the FDA PMA Application for RefluxStop® for US market approval )
Also on site :